These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38523956)

  • 1. Innovations in Diabetic Macular Edema Management: A Comprehensive Review of Automated Quantification and Anti-vascular Endothelial Growth Factor Intervention.
    Sharma S; Daigavane S; Shinde P
    Cureus; 2024 Feb; 16(2):e54752. PubMed ID: 38523956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Macular Edema Management: A Review of Anti-Vascular Endothelial Growth Factor (VEGF) Therapies.
    Cheema AA; Cheema HR
    Cureus; 2024 Jan; 16(1):e52676. PubMed ID: 38264181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Artificial Intelligence in Precision Medicine for Diabetic Macular Edema.
    Li L; Zhang W; Tu X; Pang J; Lai IF; Jin C; Cheung CY; Lin H
    Asia Pac J Ophthalmol (Phila); 2023 Sep-Oct 01; 12(5):486-494. PubMed ID: 36650089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolving Treatment of Diabetic Retinopathy.
    Mansour SE; Browning DJ; Wong K; Flynn HW; Bhavsar AR
    Clin Ophthalmol; 2020; 14():653-678. PubMed ID: 32184554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology.
    Al Qassimi N; Kozak I; Al Karam M; Neri P; Aduriz-Lorenzo PM; Attawan A; Awadalla M; El Khashab A; Abdul-Nabi M; Safar A; Al Shamsi H; Rao P; Rao M; Farid A; Gurbaxani A;
    Ophthalmol Ther; 2022 Oct; 11(5):1937-1950. PubMed ID: 35896888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.
    Guo H; Li W; Nie Z; Zhang X; Jiao M; Bai S; Duan N; Li X; Hu B
    Trials; 2023 Oct; 24(1):685. PubMed ID: 37875997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing treatment for diabetic macular edema during cataract surgery.
    Chan LKY; Lin SS; Chan F; Ng DS
    Front Endocrinol (Lausanne); 2023; 14():1106706. PubMed ID: 36761187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.
    Mi X; Gu X; Yu X
    Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications.
    Zhang J; Zhang J; Zhang C; Zhang J; Gu L; Luo D; Qiu Q
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab for the management of diabetic macular edema.
    Stefanini FR; Arevalo JF; Maia M
    World J Diabetes; 2013 Apr; 4(2):19-26. PubMed ID: 23593532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor therapy for diabetic macular edema.
    Boyer DS; Hopkins JJ; Sorof J; Ehrlich JS
    Ther Adv Endocrinol Metab; 2013 Dec; 4(6):151-69. PubMed ID: 24324855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
    Debourdeau E; Medard R; Chamard C; Nguyen V; Gabrielle PH; Creuzot-Garcher C; Allieu S; Gillies MC; Barthelmes D; Daien V;
    Ophthalmol Ther; 2023 Oct; 12(5):2657-2670. PubMed ID: 37505396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetic macular edema in Japan: a review and expert opinion.
    Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T
    Jpn J Ophthalmol; 2018 Jan; 62(1):1-23. PubMed ID: 29210010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.
    Dervenis N; Mikropoulou AM; Tranos P; Dervenis P
    Adv Ther; 2017 Jun; 34(6):1270-1282. PubMed ID: 28484955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic macular edema: Current management 2013.
    Arevalo JF
    World J Diabetes; 2013 Dec; 4(6):231-3. PubMed ID: 24379911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Retina Specialists Clinical Practice Guidelines on the Management of Nonproliferative and Proliferative Diabetic Retinopathy without Diabetic Macular Edema.
    Yonekawa Y; Modi YS; Kim LA; Skondra D; Kim JE; Wykoff CC
    J Vitreoretin Dis; 2020 Mar; 4(2):125-135. PubMed ID: 34308094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
    Uludag G; Hassan M; Matsumiya W; Pham BH; Chea S; Trong Tuong Than N; Doan HL; Akhavanrezayat A; Halim MS; Do DV; Nguyen QD
    Expert Opin Biol Ther; 2022 Oct; 22(10):1275-1291. PubMed ID: 35818801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological agents in development for diabetic macular edema.
    Sadiq MA; Halim MS; Hassan M; Onghanseng N; Karaca I; Agarwal A; Afridi R; Sepah YJ; Do DV; Nguyen QD
    Int J Retina Vitreous; 2020; 6():29. PubMed ID: 32670612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-VEGF for the management of diabetic macular edema.
    Stefanini FR; Badaró E; Falabella P; Koss M; Farah ME; Maia M
    J Immunol Res; 2014; 2014():632307. PubMed ID: 24741610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.